We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
901
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $352K | 0.04% |
3,856
-1,402
| -27% | -$97.6K |
|
|
SIRE
902
DELISTED
Sisecam Resources LP
SIRE
| $352K | 0.04% |
13,834
-2,522
| -15% | -$61K |
|
|
VRTV
903
DELISTED
VERITIV CORPORATION
VRTV
| $351K | 0.04% |
13,337
-2,558
| -16% | -$78.2K |
|
|
DS
904
DELISTED
Drive Shack Inc.
DS
| $351K | 0.04% |
78,181
-60,854
| -44% | -$274K |
|
905
Ennis
EBF
$564M
| $350K | 0.04% |
16,858
-7,951
| -32% | -$164K |
|
906
Green Dot
GDOT
$745M
| $349K | 0.04% |
+5,754
| New | +$401K |
|
907
Stock Yards Bancorp
SYBT
$2.6B
| $349K | 0.04% |
10,322
-9,728
| -49% | -$340K |
|
908
Forrester Research
FORR
$228M
| $347K | 0.04% |
+7,185
| New | +$335K |
|
909
LKQ Corp
LKQ
$6.29B
| $346K | 0.04% |
12,202
-589
| -5% | -$15.9K |
|
910
Starwood Property Trust
STWD
$6.09B
| $346K | 0.04% |
+15,471
| New | +$337K |
|
|
DBD
911
DELISTED
Diebold Nixdorf Incorporated
DBD
| $346K | 0.04% |
+31,230
| New | +$218K |
|
912
Mercer International
MERC
$39.8M
| $345K | 0.04% |
25,504
-11,066
| -30% | -$152K |
|
|
LPT
913
DELISTED
Liberty Property Trust
LPT
| $345K | 0.04% |
+7,120
| New | +$332K |
|
914
Assured Guaranty
AGO
$3.34B
| $343K | 0.03% |
7,727
+2,502
| +48% | +$104K |
|
915
American Public Education
APEI
$940M
| $343K | 0.03% |
11,389
-7,750
| -40% | -$239K |
|
|
RFP
916
DELISTED
Resolute Forest Products Inc.
RFP
| $343K | 0.03% |
43,397
+4,590
| +12% | +$38.4K |
|
917
Kinross Gold
KGC
$32.8B
| $342K | 0.03% |
+99,278
| New | +$331K |
|
|
CLR
918
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $342K | 0.03% |
7,643
-3,485
| -31% | -$156K |
|
919
Illinois Tool Works
ITW
$85.3B
| $341K | 0.03% |
+2,377
| New | +$329K |
|
920
Yum! Brands
YUM
$41.1B
| $339K | 0.03% |
+3,401
| New | +$322K |
|
921
Bausch Health
BHC
$2.34B
| $338K | 0.03% |
13,700
-41,600
| -75% | -$994K |
|
922
Flowers Foods
FLO
$1.57B
| $338K | 0.03% |
+15,843
| New | +$318K |
|
|
OPLN
923
Openlane
OPLN
$4.54B
| $338K | 0.03% |
17,387
-28,066
| -62% | -$529K |
|
|
DOOR
924
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $338K | 0.03% |
+6,766
| New | +$360K |
|
|
BEAT
925
DELISTED
BioTelemetry, Inc.
BEAT
| $338K | 0.03% |
+5,399
| New | +$371K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.